Maximising Oncology Product Value: Developing Evidence For Payors, Patients, and Physicians

oncology, product, evidence, market access, payors, patients, physicians 

The oncology market represents a huge piece of the pharmaceutical industry and continues to grow at rapid pace.  But how to develop product value has always been a question of concern.

This presentation by Josephine A. Sollano, Vice President, Health Economics And Outcomes Research And Medical Communications, Pfizer Oncology Business Unit touches on the key points on developing and defining value, it's relation to stakeholders needs and personalised medicine, as well as communicating value.

Download the presentation

In this presentation you will learn:

  • How to develop value
  • What is personalised medicine and is it the way forward
  • Potential impact of personalised medicine on healthcare spending
  • How to engage payors
  • Impact of Targeted Drug Development on HEOR Activities
  • Communicating value

Download the presentation

For more on Market Access, join us at Market Access World USA 2013 held this 23-24 October in Boston, MA.  Download the brochure for more information

Leave a Reply

Your email address will not be published. Required fields are marked *